Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
10/2005
10/12/2005CN1680258A Amorphous water-soluble calcium citrate salts and method of making and using same
10/12/2005CN1680257A Preparation of levulinate from glucose by molecular screen catalytic hydrolysis
10/12/2005CN1680256A Extracting production of refining calcium lactate by supercritical fluid carbon dioxide
10/12/2005CN1680241A Process for preparing fluorohalogenethers
10/12/2005CN1222497C Process for preparing ether carboxylate
10/11/2005US6953860 Process for preparing 1,5-diaryl-3-substituted pyrazoles
10/06/2005WO2005092317A1 Thyroid receptor agonists
10/06/2005US20050222213 Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
10/06/2005CA2562633A1 Thyroid receptor agonists
10/05/2005EP1581536A2 Epothilone derivatives
10/05/2005EP1581471A1 Cyclopentenone derivatives for cancer therapy
10/05/2005EP1084693B1 Alpha-hydroxy fatty acid derivatives and composition for external use containing the same
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951957 Process for producing a fluorine-containing compound by liquid phase fluorination
10/04/2005US6951956 Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof
10/04/2005US6951844 substituted 5-phenyl-2-naphthols; metabolic disorders
09/2005
09/29/2005WO2005090278A1 Alphahydroxyacids with ultra-low metal concentration
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215563 Proteomimetic compounds and methods
09/28/2005EP1578716A1 Dicarboxylic acid derivatives as ppar-agonists
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578714A1 Novel chiral compounds derived from hexanoic acid esters, method and intermediate chemicals for the preparation and use thereof for synthesis of 2-(bromomethyl)2-ethyl hexanoic chiral acid
09/28/2005EP1265838B1 Novel fatty acid analogous
09/28/2005EP1187800A4 Improved process for the preparation of 3,4-dihydroxybutanoic acid and salts and lactones derived therefrom
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators
09/28/2005CN1220692C Process for preparing cephalotaxane derivatives
09/27/2005US6949664 Acyclic unsaturated alcohols such as lipoxins, prepared by hydrogenation in the presence of lindlar's catalysts, for use as antiinflammmatory or antiproliferative agents
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005US20050209336 EP2 receptor agonists
09/22/2005US20050209328 Alphahydroxyacid and one or more metals wherein the total metal concentration is less than 1000 mu g/kg and the concentration of any individual metal of the composition is less than 250 mu g/kg; use as post-etch cleaners in processing electronic devices such as semiconductors
09/21/2005EP1576039A2 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents
09/21/2005EP1575532A2 Mixed esters of dicarboxylic acids for use as pigment dispersants
09/21/2005CN1670008A Process for preparing Danshensu
09/21/2005CN1219771C Process for preparing 1, 5-diaryl-3-substituted pyrazoles
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/15/2005WO2005085169A1 Skin lightening agents, compositions and methods
09/15/2005WO2005085168A1 Particles of aluminum salt hydroxide containing organic acid anion, method for production thereof and use thereof
09/15/2005WO2005085164A1 Novel triple mineral salts of (-)-hydroxycitric acid and processes for preparing the same
09/15/2005US20050203180 fewer side-effects by showing no hormone properties; enhancing the learning and memory-retention, treat dementia
09/15/2005DE102004009549A1 Performing base-catalyzed reactions comprises using a soluble polymeric base and withdrawing the product through a nano- or ultrafiltration membrane
09/15/2005CA2564630A1 Organic acid anion containing aluminum salt hydroxide particles, production method thereof, and use thereof
09/14/2005EP1574560A1 Process for solventfree production of ether carboxylic acids with a low rest salt content
09/14/2005CN1668565A Substituted 1, 3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
09/14/2005CN1668274A Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof
09/13/2005CA2189247C Recovery of carboxylic acid from organic solution that contains an amine and an extraction enhancer
09/13/2005CA2058553C Preparation of e-oxime ethers of phenylglyoxylic esters
09/09/2005WO2005082872A1 Benzothiazin-3-one compound and intermediate therefor
09/09/2005CA2560664A1 Benzothiazin-3-one compound and intermediate therefor
09/07/2005CN1663942A Method for separating mandelic acid enantiomer
09/07/2005CN1217913C Process for the preparation of alpha-arylalkanoic acids
09/07/2005CN1217907C Method for preparing p-hydroxymandelic compounds optically substituted
09/06/2005US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/06/2005CA2127754C Nonwoven based on polymeric lactic acid derivatives, and manufacturing process and use thereof
09/01/2005WO2005080340A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005WO2005080309A1 Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
09/01/2005US20050192449 chemical intermediates; for oral administration with improved absorption; antiestrogens; antitumor agents
09/01/2005US20050192350 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents
09/01/2005US20050191250 Skin lightening agents, compositions and methods
09/01/2005DE102004050703A1 New calcium lactate malate useful as a food additive or for producing pharmaceutical compositions, especially for treating osteoporosis
09/01/2005CA2556348A1 Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
09/01/2005CA2555814A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
08/2005
08/31/2005EP1163204B1 Lipoxin compounds and their use
08/31/2005CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma
08/31/2005CN1660761A Method for deprivig sulfur dioxide in solution of citrate
08/30/2005US6936722 Polyhalogenated ethers
08/30/2005US6936636 5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187255 Novel curcumin analogues and uses thereof
08/24/2005EP1566374A1 Process for preparing fluorohalogenethers
08/24/2005EP1566373A1 Amorphous water-soluble calcium citrate salts and method of making and using same.
08/24/2005EP1565422A1 Vitamin d receptor modulators
08/24/2005CN1659130A Induction of apoptosis in cancer cells
08/24/2005CN1216034C Malic acid addition salts of terbinafine
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005CA2469592C Hiv integrase inhibitors
08/18/2005WO2005075408A1 L-(-)-moprolol l-(+)-tartrate
08/18/2005US20050181096 Powdered beverage mixes and liquid compositions fortified with amorphous water-soluble calcium citrate salts as a calcium source
08/17/2005EP1564217A2 Process for the production of epothilones
08/17/2005EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses
08/17/2005EP1563829A1 Zinc gluconate composition containing acicular particles
08/16/2005CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/11/2005WO2005073184A1 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
08/11/2005WO2005073164A1 Therapeutic and carrier molecules
08/11/2005US20050176808 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
08/11/2005US20050176689 For therapy, useful as regulators of cell proliferation and differentiation, and particularly as agents for treating skin-related diseases
08/11/2005CA2554735A1 Therapeutic and carrier molecules
08/11/2005CA2550576A1 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
08/10/2005EP1228028B1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
08/10/2005EP0939752B1 Manufacture of fluorinated compounds
08/10/2005CN1653032A Substituted phenylalkanoic acid derivatives and use thereof
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/09/2005US6927224 Anticancer agents; osteoporosis
08/04/2005WO2005070863A1 An athermal process for the concentration of garcinia extract
08/04/2005US20050171381 Process for preparing fluorocarboxylic acids
08/04/2005US20050171149 antioxidant properties and peroxisome proliferator activated receptors (PPAR) alpha and PPAR gamma activator properties; cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms, neurodegenerative, and skin disorders
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 147